Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Brittany R Eberl
Observed names:
B.R. Eberl,
Brittany Eberl,
Brittany R. Eberl
Institutions:
Baylor College of Medicine,
Dan L Duncan Comprehensive Cancer Center
Observed institutions:
University of South Carolina,
Baylor College of Medicine,
Dan L Duncan Comprehensive Cancer Center,
The University of Texas at Austin
ORCID:
0000-0002-2584-4969
Observed ORCID:
0000-0002-2584-4969
OpenAlex ID:
A5099184194
Delayed cognitive impairments in a rat model of Gulf War Illness are stimulus-dependent
2023
·
H.E. Burzynski
, K.E. Ayala
, et al.
·
Brain Behavior and Immunity
·
5
Targeting SAGA/ATAC complexes disrupts chromatin regulation and cholesterol metabolism in diffuse midline glioma
2026
·
Rosemary U. Richard
, Caitlin L. Bagnetto
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
PDF
Immu-18. Enhancing Gd2.car T Cell Therapy for Diffuse Midline Glioma With Lsd1 and Hdac Inhibitors
2024
·
Rebecca L Murdaugh
, Meghan Shekar
, et al.
·
Neuro-Oncology
·
1
PDF
H3 dopaminylation and CaMKII modulate diffuse midline glioma response to CDK9 inhibition
2026
·
Rebecca L. Murdaugh
, Brittany R. Eberl
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
DMG-57. Targeting neurotransmitter signaling to overcome resistance to CDK9 inhibitors in diffuse midline glioma
2025
·
Rebecca Murdaugh
, Brittany Eberl
, et al.
·
Neuro-Oncology Pediatrics
Exth-47. Enhancing Gd2.cart Therapy for Diffuse Midline Glioma With Lsd1 and Hdac Inhibitors
2024
·
Rebecca Murdaugh
, Meghan Shekar
, et al.
·
Neuro-Oncology
PDF
Dddr-44. Repurposing Ssri/snri Targeting Neurotransmitter Signaling to Overcome Resistance to Cdk9 Inhibitors in Diffuse Midline Glioma
2024
·
Rebecca L Murdaugh
, Brittany R Eberl
, et al.
·
Neuro-Oncology
PDF
Dipg-74. Targeting Transcriptional Dysregulation in Dmg Through Cdk9 and Hdac Inhibitor Combination Therapy
2024
·
Brittany R Eberl
, Rebecca L Murdaugh
, et al.
·
Neuro-Oncology
PDF
Modl-12. Repurposing Ssri/snri Targeting Neurotransmitter Signaling to Sensitize Dmg to Cdk9 Inhibitors
2024
·
Rebecca L Murdaugh
, Brittany R Eberl
, et al.
·
Neuro-Oncology
Show more works
View as search
Works count:
9
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type